Meet Octavia

Posted by
August 4, 2026
myStoria Partnerships: A new community perk. Real relief, in the mail. A plant-based perk, made for any body.

Pelvic pain doesn't check your chart before it shows up. It doesn't care what your diagnosis is, whether you have one yet, or what gender you are. It arrives, and then you're doing the math about whether today is a "push through it" day or a "cancel everything" day.

Octavia makes one thing for that pain: a plant-based suppository called Ease Please, made for anyone who can use CBD products, any gender, for pelvic or general pain. It can be used vaginally or rectally. Each one contains 150mg of broad-spectrum CBD in a base of organic cocoa butter and vitamin E. Broad-spectrum means no THC, so there's no "high." They melt at body temperature, and Octavia suggests lying down for 20 to 30 minutes after insertion.

Octavia describes Ease Please as 100% plant-based and hormone-safe, with vegan botanicals and no synthetic ingredients, fillers, or endocrine-disruptive chemicals. In their words, they're clean, plant-based products designed to help manage your symptoms naturally.

Many of the people reaching for something like this are living with endometriosis, and Octavia's education speaks to that community directly. They frame endo as a whole-body inflammatory disease, not a "bad period," and they include ...

Want to keep reading?

Only myStoria members can read the rest of this article. It's free to join with the myStoria app!
Download on the App StoreGet It On Google Play
Already a member?
Click here to open this article in the myStoria community.
About the Author

Carly Malo is myStoria's Head of Concierge. She has 2 decades of experience in direct nursing care, having worked in long-term care, sports medicine, practical nursing, and fertility/reproductive health.

myStoria app icon
Stop holding it all in your head.
Download on the App StoreGet It On Google Play
Medical app screen showing a timeline of health story points including appointments, test results, nurse check-in, and diagnosis with dates from December 2025 to February 2026.